DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately six "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

04 Jan 2011

Successful Drug Development

Biotech Sweden inviterer til seminar torsdag den 13. Januar 2011 kl. 8:30 – 17.00
Malmö Börshus, Skeppsbron 2, Malmö.

Program:
08.30 Registration and breakfast

09:00 Jörgen Lindqvist, Editor-in-chief, Biotech Sweden
Introduction

09:05 Mats Lindorff, venture capitalist, former Innovation Manager at Lund university and CTO at Sonyericsson
Value chain shift – inspiration from the mobile phone industry

09:40 Nina Lindblom, Manager Early Phase Studies, IRW Consulting
Points to consider in optimizing drug development – bridging the gap from preclinical to phase II studies

10:05 Paul Alhadeff, General Manager and Co-Founder, Syntagon
Supply of active substance during the drug development stage

10:30 Break with refreshments

10:45 Jan Mattson, Director Clinical Outsourcing, Astrazeneca
AstraZeneca outsourcing strategies – why and how Big Pharma are using CROs

11:10 Jan Hellqvist, Regional Managing Director, TFS Nordics
Strategical partnership between CRO and sponsor

11:35 Maria Stenbäck, Senior European Patent Attorney, AwaPatent
Intellectual property aspects on cooperation with CROs and CMOs – Important considerations

12:00 Lunch

13:00 Knut T Smerud, Chairman & Founder, Smerud Medical Research CRO Group
How your CRO can help you attract public research grants for clinical trials

13:25 Sverre Bengtsson, co-founder Pharma Consulting Group
Using your data to maximize clinical trial efficiency

13:50 Petter Ericsson, inventor, Anoto
Digital pen and paper in clinical trials data capture – advantages and shortcomings in practical use

14:15 Break with refreshments

14:30 Alain Scarso, Managing Director, Polypetide
Outsourcing manufacturing and process development of API’s in expertise area’s

14:55 Jonas Berggren, Formulation Development Manager, Recipharm
Formulation development – examples of possibilities and pitfalls

15:20 Break with refreshments

15:35 Michael Brobjer, Director Marketing & Business Development, APL
Your success is our success – get the most from your CMO through a true partnership

16:00 Christina Åkerman, Director-General, Swedish Medical Products Agency, Anthony Baker, Managing Director UK, NDA
Medical product agencies – obstacles or opportunities for successful drug development?

16:40 Panel discussion

17:00 Mingle

Register today as the number of participants is limited!

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2011 Danskbiotek. All rights reserved.